Adapting Cancer Care for the LGBT Community

Article

Patients with cancer who are also a part of the LGBT community often face barriers when it comes to the care and treatment for their disease.

While cancer does not know sexual orientation or gender preference, health care providers do, and this can often create barriers for certain patients.

At the 2016 Oncology Nursing Society (ONS) 41st Annual Congerss, Liz Margolies, LCSW, founder and executive director of the National LGBT Cancer Network, spoke about the problems members of the lesbian, gay, bisexual and transgender (LGBT) community face when it comes to cancer care.

As a crowd of oncology nurses filled the room, she drove home the point that LGBT people come to cancer with a different history and therefore a different way of being treated for cancer—their sexual orientation should matter. Some have been shunned by their family and friends for coming out, while others have been bullied at school or work, and some 37 percent have experienced harassment in a hospital or doctor’s office.

Discrimination like that can lead a person down a dark path of coping behavior such as abusing tobacco, drugs and alcohol. The stress may also lead to obesity and lower cancer screening rates. All of these behaviors put the LGBT community at high risk for cancer.

“The essence of good cancer treatment is not just skillful surgery, effective chemotherapy and follow-up care, but it includes the whole person,” said Margolies. “And that means understanding who her support system is, what her sexual orientation is, and what her gender identity is.”

A startling statistic Margolies shared was that 50 percent of transgender people had to teach their healthcare professional how to treat them. That could be related to the fact that only five hours of LGBT learning is provided throughout medical school.

The lack of provider knowledge has pushed many in the LGBT community away or even “back into the closet” when it comes to cancer care. When the time comes that they do seek treatment for cancer they are wary at first. For instance, 75 percent of lesbian women delay or avoid healthcare because of the cost, fear of discrimination or from having a prior negative experience with the healthcare system.

In a video, the audience followed the journeys of three people: Jay Kallio, Jo and Vanessa. Kallio, identified as a transgender man who has had cancer twice, with this second diagnosis revealing a highly aggressive lung cancer. He believes the cancer was brought on by the stress and exhaustion of fighting his whole life. Kallio hit a new low when he was turned away from a doctor after he revealed he was transgender and was then referred for psychiatric care.

Jo, who knew she was a lesbian at the age of 16, was rejected by her own family after coming out. She developed a terminal cancer later in life and developed her own support system. Jo died on Oct. 15, 2014.

Vanessa, who was born Robert, discussed her trip to the doctor. She had a negative experience because medical forms didn’t allow her to identify who she was and the doctor didn’t know how to treat her.

“One out of five transgender people report being sent away by a healthcare provider who says ‘I don’t understand your body — I can’t treat you.’ This does not encourage people from going back to the doctor,” Margolies said.

But experiences for LGBT patients with cancer can be improved—and begins with healthcare professionals. Big changes can be made right in doctors’ offices, hospitals or on company websites that welcome LGBT patients. This can be done by posting a non-discrimination policy or by posting the LGBT pride symbol, a rainbow flag on a wall or window or by displaying an LGBT couple on a website homepage.

Medical forms could be modified to provide a space for an LGBT patient to disclose how they identify and who their support system is. Currently, only 2 percent of healthcare organizations have intake forms that have a place for this, according to a poll discussed during the lecture.

Margolies encouraged nurses to learn about LGBT, so they can be a resource. She also told them to get involved with LGBT organizations and leaders in order to be an ally to their patients.

“To get the respect and trust of the LGBT community, it’s going to take more than all of you becoming experts here,” said Margolies. “It means training everybody in your organization. If an LGBT organization community supports you and you work together, it’s the best way for you to learn. It shows that your office is a safe place to be.”

In her final thoughts, Margolies told the oncology nurses to feel free to make a mistake — that even if you get it wrong, it demonstrates that you care enough to ask. She even shared a quote that her aunt used to say to her: “Anything worth doing is worth doing poorly at first.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content